Cargando…
An Extracellular Matrix Molecule, Secreted by the Epithelial-Mesenchymal Transition is Associated With Lymph Node Metastasis of Thyroid Papillary Carcinoma
BACKGROUND: Papillary thyroid carcinoma often has lymph node metastasis, compared with follicular thyroid carcinoma. The study showed that epithelial-mesenchymal transition occurs in carcinoma cells during the first stage of metastasis, where some extracellular matrix molecules are secreted in large...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kowsar
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3960592/ https://www.ncbi.nlm.nih.gov/pubmed/24696692 http://dx.doi.org/10.5812/ijem.10748 |
_version_ | 1782308177093591040 |
---|---|
author | Takeyama, Hiroshi Manome, Yoshinobu Fujioka, Kouki Tabei, Isao Nogi, Hiroko Toriumi, Yasuo Kato, Kumiko Kamio, Makiko Imawari, Yoshimi Kinoshita, Satoki Akiba, Naoshi Uchida, Ken Morikawa, Toshiaki |
author_facet | Takeyama, Hiroshi Manome, Yoshinobu Fujioka, Kouki Tabei, Isao Nogi, Hiroko Toriumi, Yasuo Kato, Kumiko Kamio, Makiko Imawari, Yoshimi Kinoshita, Satoki Akiba, Naoshi Uchida, Ken Morikawa, Toshiaki |
author_sort | Takeyama, Hiroshi |
collection | PubMed |
description | BACKGROUND: Papillary thyroid carcinoma often has lymph node metastasis, compared with follicular thyroid carcinoma. The study showed that epithelial-mesenchymal transition occurs in carcinoma cells during the first stage of metastasis, where some extracellular matrix molecules are secreted in large quantities. Sialic acid carried by fibronectin as the antigen of the monoclonal antibody (MoAb) JT-95, was detected in 90% of papillary thyroid carcinoma cases, and in a few follicular thyroid carcinomas, in the extracellular matrix of thyroid carcinoma cells. OBJECTIVES: The current study was conducted to investigate the association between increasing the number of extracellular matrix molecules, fibronectin, and lymph node metastasis. We also co-cultured a thyroid carcinoma cell line and lymphocyte cell line, with and without MoAb JT-95, in order to investigate the mechanism of cell to cell interaction. PATIENTS AND METHODS: Immunostaining with JT-95 was performed in 45 papillary thyroid carcinoma cases, and 20 follicular type tumors, to investigate the association between the quantity of fibronectin expression and the frequency of lymph node metastasis. The thyroid carcinoma cell line (SW1736), which secreted fibronectin, and the B cell-lymphoma cell line (Daudi), which held integrin on the cell surface, were co-cultured to observe the adhesion of cells to each other. The SW1736 cell line, pretreated with JT-95, was also co-cultured with the Daudi cell line. RESULTS: There were 39 cases with lymph node metastasis in 59 malignant tumors, and 0 cases in 6 benign follicular type tumors. The staining scores by JT-95 of the 39 tumors with lymph node metastasis were 5+ in eight cases and 6+ in 31 cases. On the other hand, the scores of 20 malignant tumors without lymph node metastasis were < 4+ in all of the cases. In the co-cultured assay, numerous adhesions were observed between the SW1736 and Daudi cells. In contrast, the inhibition of adherences was observed in proportion to the concentrations of JT-95. CONCLUSIONS: Increased fibronectin expression in thyroid malignancies is correlated with lymph node metastasis. |
format | Online Article Text |
id | pubmed-3960592 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Kowsar |
record_format | MEDLINE/PubMed |
spelling | pubmed-39605922014-04-02 An Extracellular Matrix Molecule, Secreted by the Epithelial-Mesenchymal Transition is Associated With Lymph Node Metastasis of Thyroid Papillary Carcinoma Takeyama, Hiroshi Manome, Yoshinobu Fujioka, Kouki Tabei, Isao Nogi, Hiroko Toriumi, Yasuo Kato, Kumiko Kamio, Makiko Imawari, Yoshimi Kinoshita, Satoki Akiba, Naoshi Uchida, Ken Morikawa, Toshiaki Int J Endocrinol Metab Research Article BACKGROUND: Papillary thyroid carcinoma often has lymph node metastasis, compared with follicular thyroid carcinoma. The study showed that epithelial-mesenchymal transition occurs in carcinoma cells during the first stage of metastasis, where some extracellular matrix molecules are secreted in large quantities. Sialic acid carried by fibronectin as the antigen of the monoclonal antibody (MoAb) JT-95, was detected in 90% of papillary thyroid carcinoma cases, and in a few follicular thyroid carcinomas, in the extracellular matrix of thyroid carcinoma cells. OBJECTIVES: The current study was conducted to investigate the association between increasing the number of extracellular matrix molecules, fibronectin, and lymph node metastasis. We also co-cultured a thyroid carcinoma cell line and lymphocyte cell line, with and without MoAb JT-95, in order to investigate the mechanism of cell to cell interaction. PATIENTS AND METHODS: Immunostaining with JT-95 was performed in 45 papillary thyroid carcinoma cases, and 20 follicular type tumors, to investigate the association between the quantity of fibronectin expression and the frequency of lymph node metastasis. The thyroid carcinoma cell line (SW1736), which secreted fibronectin, and the B cell-lymphoma cell line (Daudi), which held integrin on the cell surface, were co-cultured to observe the adhesion of cells to each other. The SW1736 cell line, pretreated with JT-95, was also co-cultured with the Daudi cell line. RESULTS: There were 39 cases with lymph node metastasis in 59 malignant tumors, and 0 cases in 6 benign follicular type tumors. The staining scores by JT-95 of the 39 tumors with lymph node metastasis were 5+ in eight cases and 6+ in 31 cases. On the other hand, the scores of 20 malignant tumors without lymph node metastasis were < 4+ in all of the cases. In the co-cultured assay, numerous adhesions were observed between the SW1736 and Daudi cells. In contrast, the inhibition of adherences was observed in proportion to the concentrations of JT-95. CONCLUSIONS: Increased fibronectin expression in thyroid malignancies is correlated with lymph node metastasis. Kowsar 2014-01-01 2014-01 /pmc/articles/PMC3960592/ /pubmed/24696692 http://dx.doi.org/10.5812/ijem.10748 Text en Copyright © 2014, Research Institute For Endocrine Sciences and Iran Endocrine Society http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Takeyama, Hiroshi Manome, Yoshinobu Fujioka, Kouki Tabei, Isao Nogi, Hiroko Toriumi, Yasuo Kato, Kumiko Kamio, Makiko Imawari, Yoshimi Kinoshita, Satoki Akiba, Naoshi Uchida, Ken Morikawa, Toshiaki An Extracellular Matrix Molecule, Secreted by the Epithelial-Mesenchymal Transition is Associated With Lymph Node Metastasis of Thyroid Papillary Carcinoma |
title | An Extracellular Matrix Molecule, Secreted by the Epithelial-Mesenchymal Transition is Associated With Lymph Node Metastasis of Thyroid Papillary Carcinoma |
title_full | An Extracellular Matrix Molecule, Secreted by the Epithelial-Mesenchymal Transition is Associated With Lymph Node Metastasis of Thyroid Papillary Carcinoma |
title_fullStr | An Extracellular Matrix Molecule, Secreted by the Epithelial-Mesenchymal Transition is Associated With Lymph Node Metastasis of Thyroid Papillary Carcinoma |
title_full_unstemmed | An Extracellular Matrix Molecule, Secreted by the Epithelial-Mesenchymal Transition is Associated With Lymph Node Metastasis of Thyroid Papillary Carcinoma |
title_short | An Extracellular Matrix Molecule, Secreted by the Epithelial-Mesenchymal Transition is Associated With Lymph Node Metastasis of Thyroid Papillary Carcinoma |
title_sort | extracellular matrix molecule, secreted by the epithelial-mesenchymal transition is associated with lymph node metastasis of thyroid papillary carcinoma |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3960592/ https://www.ncbi.nlm.nih.gov/pubmed/24696692 http://dx.doi.org/10.5812/ijem.10748 |
work_keys_str_mv | AT takeyamahiroshi anextracellularmatrixmoleculesecretedbytheepithelialmesenchymaltransitionisassociatedwithlymphnodemetastasisofthyroidpapillarycarcinoma AT manomeyoshinobu anextracellularmatrixmoleculesecretedbytheepithelialmesenchymaltransitionisassociatedwithlymphnodemetastasisofthyroidpapillarycarcinoma AT fujiokakouki anextracellularmatrixmoleculesecretedbytheepithelialmesenchymaltransitionisassociatedwithlymphnodemetastasisofthyroidpapillarycarcinoma AT tabeiisao anextracellularmatrixmoleculesecretedbytheepithelialmesenchymaltransitionisassociatedwithlymphnodemetastasisofthyroidpapillarycarcinoma AT nogihiroko anextracellularmatrixmoleculesecretedbytheepithelialmesenchymaltransitionisassociatedwithlymphnodemetastasisofthyroidpapillarycarcinoma AT toriumiyasuo anextracellularmatrixmoleculesecretedbytheepithelialmesenchymaltransitionisassociatedwithlymphnodemetastasisofthyroidpapillarycarcinoma AT katokumiko anextracellularmatrixmoleculesecretedbytheepithelialmesenchymaltransitionisassociatedwithlymphnodemetastasisofthyroidpapillarycarcinoma AT kamiomakiko anextracellularmatrixmoleculesecretedbytheepithelialmesenchymaltransitionisassociatedwithlymphnodemetastasisofthyroidpapillarycarcinoma AT imawariyoshimi anextracellularmatrixmoleculesecretedbytheepithelialmesenchymaltransitionisassociatedwithlymphnodemetastasisofthyroidpapillarycarcinoma AT kinoshitasatoki anextracellularmatrixmoleculesecretedbytheepithelialmesenchymaltransitionisassociatedwithlymphnodemetastasisofthyroidpapillarycarcinoma AT akibanaoshi anextracellularmatrixmoleculesecretedbytheepithelialmesenchymaltransitionisassociatedwithlymphnodemetastasisofthyroidpapillarycarcinoma AT uchidaken anextracellularmatrixmoleculesecretedbytheepithelialmesenchymaltransitionisassociatedwithlymphnodemetastasisofthyroidpapillarycarcinoma AT morikawatoshiaki anextracellularmatrixmoleculesecretedbytheepithelialmesenchymaltransitionisassociatedwithlymphnodemetastasisofthyroidpapillarycarcinoma AT takeyamahiroshi extracellularmatrixmoleculesecretedbytheepithelialmesenchymaltransitionisassociatedwithlymphnodemetastasisofthyroidpapillarycarcinoma AT manomeyoshinobu extracellularmatrixmoleculesecretedbytheepithelialmesenchymaltransitionisassociatedwithlymphnodemetastasisofthyroidpapillarycarcinoma AT fujiokakouki extracellularmatrixmoleculesecretedbytheepithelialmesenchymaltransitionisassociatedwithlymphnodemetastasisofthyroidpapillarycarcinoma AT tabeiisao extracellularmatrixmoleculesecretedbytheepithelialmesenchymaltransitionisassociatedwithlymphnodemetastasisofthyroidpapillarycarcinoma AT nogihiroko extracellularmatrixmoleculesecretedbytheepithelialmesenchymaltransitionisassociatedwithlymphnodemetastasisofthyroidpapillarycarcinoma AT toriumiyasuo extracellularmatrixmoleculesecretedbytheepithelialmesenchymaltransitionisassociatedwithlymphnodemetastasisofthyroidpapillarycarcinoma AT katokumiko extracellularmatrixmoleculesecretedbytheepithelialmesenchymaltransitionisassociatedwithlymphnodemetastasisofthyroidpapillarycarcinoma AT kamiomakiko extracellularmatrixmoleculesecretedbytheepithelialmesenchymaltransitionisassociatedwithlymphnodemetastasisofthyroidpapillarycarcinoma AT imawariyoshimi extracellularmatrixmoleculesecretedbytheepithelialmesenchymaltransitionisassociatedwithlymphnodemetastasisofthyroidpapillarycarcinoma AT kinoshitasatoki extracellularmatrixmoleculesecretedbytheepithelialmesenchymaltransitionisassociatedwithlymphnodemetastasisofthyroidpapillarycarcinoma AT akibanaoshi extracellularmatrixmoleculesecretedbytheepithelialmesenchymaltransitionisassociatedwithlymphnodemetastasisofthyroidpapillarycarcinoma AT uchidaken extracellularmatrixmoleculesecretedbytheepithelialmesenchymaltransitionisassociatedwithlymphnodemetastasisofthyroidpapillarycarcinoma AT morikawatoshiaki extracellularmatrixmoleculesecretedbytheepithelialmesenchymaltransitionisassociatedwithlymphnodemetastasisofthyroidpapillarycarcinoma |